PRODUCTWATCH
FDA Got Tired Of Waiting For Philips To Do The Right Thing With CPAP — SO THEY ’ RE MAKING THEM DO IT
By Sara Stephens
The U . S . Food and Drug Administration ( FDA ) has called out Philips Respironics for its inadequate efforts in notifying patients , suppliers , and healthcare providers of a massive recall of some of the company ’ s breathing assistance devices . On March 10 , 2022 , the agency ordered the company to notify these users of the recall and the products ’ risks .
It ’ s a move that Levin Papantonio Rafferty attorney Troy Bouk called a “ strong statement ” from the federal agency . Bouk , an attorney with Levin Papantonio Rafferty , was appointed to the Science and Expert Committee for the Philips CPAP multidistrict litigation . The FDA order appears to have had at least some effect . By March 14 , 2022 , the FDA had updated its Philips Respironics breathing CPAP , BiPAP , and Ventilator
Recalls FAQ page to include details about how the manufacturer will prioritize replacement devices .
28 x The Trial Lawyer